Loading viewer...
investor_presentation
Format: PDF investor_presentation
Camallergy is a clinical-stage biotech company developing peanut oral immunotherapy (OIT) treatments. The presentation outlines the company's leadership team, clinical operations, and regulatory pathway, featuring executives with extensive experience in immunology, allergy treatment, and pharmaceutical commercialization.
investor_presentation
10 Pages
Aralez Pharmaceuticals
HDFC Nifty LargeMidcap 250 Index Fund 2024 Launch
investor_presentationinvestor_presentation
20 Pages
HDFC Asset Management Company